Summary
1. The effect of bradykinin (BK) and some analogues of BK on the human blister base was studied. 2. BK produced reproducible dose-related increases in pain responses. A characteristic delay, which was not dose-related occurred between application of BK and the resultant response. 3. The rank order of potency of several kinin analogues on the pain response was BK > > > Σ-cyclo-(Lys1-Gly6)-BK = Σ-cyclo-kallidin > des-Arg9-BK. 4. No increase in pain response was seen with repeated application of the selective B1 receptor agonist des-Arg9-BK to the same blister base at 4 h intervals. The B1 receptor antagonist des-Arg9-Leu8-BK was without effect against BK-induced responses. 5. The B2 receptor antagonists, d-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-d-Phe-Thi-Arg-TFA and d-Pro-Phe-Arg-heptylamide produced significant antagonism of the bradykinin-induced pain responses at doses which had no effect against 5-hydroxytryptamine or potassium chloride. 6. It is concluded that the kinin receptor mediating pain on the human blister base is of the B2 type.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akinosi IA, Whalley ET (1986) Expression of des-Arg9-BK sensitive (B1) receptors in vivo by captopril, bradykinin and endotoxin. Br J Pharmacol 89:731 P
Armstrong D, Dry RML, Keele CA, Markham JW (1951) Method for studying chemical excitants of cutaneous pain in man. J Physiol (Lond) 120:326–351
Armstrong D, Jepson JB, Keele CA, Stewart JW (1957) Pain producing substances in human inflammatory exudates and plasma. J Physiol (Lond) 135:350–370
Carey F, Haworth D, Whalley ET (1986) Pro-inflammatory effects of cyclic-kinin analogues. Br J Pharmacol 89:806P
Chipens GI, Mutulis FK, Katayer BS, Klusha VE, Misina IP, Myshlyiakova NV (1981) Cyclic analogue of bradykinin possessing selective and prolonged biological activity. Int J Peptide Protein Res 18:302–311
Claeson G, Fareed J, Larsson C, Kindel G, Arielly S, Simonsson R, Messmore HL, Balis JV (1979) Inhibition of the contractile action of bradykinin on isolated smooth muscle preparations by derivatives of low molecular weight peptides. In: Fujii S, Moriya H, Suzuki T (eds) Kinins II: Systemic proteases and cellular function. Plenum Press, New York, pp 691–713
Fareed J, Kindel G, Messmore HL, Balis JV (1978) Antagonism of the bradykinin-induced contractile response of isolated smooth muscle preparations by low molecular weight synthetic chromogenic peptide substrates for serine proteases. In: Haberland GL, Hamberg U (eds) Advances in the biosciences. Current concepts in kinin research, vol 17. Pergamon Press, Oxford, pp 237–247
Foster RW, Weston KM (1986) Chemical irritant algesia assessed using the human blister base. Pain 25:269–278
Holdstock DJ, Mathias AP, Schachter M (1957) A comparative study of kinin, kallidin and bradykinin. Br J Pharmacol 12:149–158
Holm S (1979) A simple sequentially multiple test procedure. Scand J Statist 6:65–70
Keele CA, Armstrong D (1964) Substances producing pain and itch. Edward Arnold, London
Marceau F, Lussier A, Regoli D, Giroud JP (1983) Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen Pharmacol 14:209–230
Regoli D, Barabe J (1980) Pharmacology of bradykinin and related kinins. Pharmacol Rev 32:1–46
Regoli D, Marceau F, Barabe J (1978) De novo formation of vascular receptor for bradykinin. Can J Physiol Pharmacol 56:674–677
Regoli D, Marceau F, Lavigne J (1981) Induction of B1 receptords for kinins in the rabbit by a bacterial lipopolysaccharide. Eur J Pharmacol 70:105–115
Schachter M (1960) Some properties of kallikrein, bradykinin and wasp venom kinin. In: Schachter M (ed) Polypeptides which affect smooth muscles and blood vessels. Pergamon, London, pp 232–236
Spraggs CF, Margolius HS, Cuthbert AW (1983) Selective activity of cyclokinins. J Pharm Pharmacol 35:266–268
Vavrek RJ, Stewart JM (1985) Competitive antagonists of bradykinin. Peptides 6:161–164
Whalley ET (1987) Receptors mediating the increase in vascular permeability to kinins: comparative studies in rat, guinea-pig and rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 336:99–104
Whalley ET, Edwads G (1982) Observations on the effect of various tripeptide analogues of bradykinin on several in vitro preparations. In: Fritz H, Dietze G, Fiedler F, Haberland G (eds) Recent progress on kinins, agents and actions supplements, vol 9. Birkhäuser, Basel Boston Stuttgart, pp 263–269
Whalley ET, Fritz H, Geiger R (1983) Kinin receptors and angiotensin converting enzyme in rabbit basilar arteries. Naunyn-Schmiedeberg's Arch Pharmacol 324:296–301
Whalley ET, Sampaio CAM, Fritz H, Edwards G (1984) The effect of kinins on paw oedema and uterus in rats. Naunyn-Schmiedeberg's Arch Pharmacol 328:202–206
Whalley ET, Nwator IA, Stewart NM, Vavrek RJ (1987) Analysis of the receptors mediating vascular actions of bradykinin. Naunyn-Schmiedeberg's Arch Pharmacol 336:430–433
Wilhelm DL (1973) Chemical mediators. In: Zweifach BW, Grant L, McCluskey RT (eds) The inflammatory process, 2nd edn, vol 2. Academic Press, New York, pp 251–301
Author information
Authors and Affiliations
Additional information
Send offprint requests to E. T. Whalle
Rights and permissions
About this article
Cite this article
Whalley, E.T., Clegg, S., Stewart, J.M. et al. The effect of kinin agonists and antagonists on the pain response of the human blister base. Naunyn-Schmiedeberg's Arch Pharmacol 336, 652–655 (1987). https://doi.org/10.1007/BF00165756
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00165756